US equities |
NVDA $178.67 ▲+0.00% MU $733.15 ▲+0.00% AMD $508.58 ▲+0.00% SNDK $886.51 ▲+0.00% SPCX $142.07 ▲+0.00% SKHY $134.38 ▲+0.00% TSLA $378.05 ▲+0.00% TSM $388.62 ▲+0.00%
FinancialContent
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
John W Hardy Announces Divorce Recovery Coaching Focused on Helping Men Rebuild Life, Identity, and Confidence
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
News headline image
Professional Guide to Buy Airtight Glass Food Containers
Via Worldnewswire
Exposures Product Safety
News headline image
Xenon (XENE) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers XENE
Exposures Financial Product Safety
Praxis Precision Medicines (NASDAQ:PRAX) Narrows Q3 Loss Ahead of Two FDA Decisions ↗
Via Chartmill
Tickers PRAX
Exposures Product Safety
News headline image
Trevi Therapeutics (TRVI) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property
Tickers TRVI
Exposures Financial Intellectual Property Product Safety
News headline image
OCUL Q3 2026 deep dive: AXPAXLI NDA submission and clinical strategy drive focus
Via StockStory
Tickers OCUL
Exposures Product Safety
News headline image
Axsome Therapeutics Tops $1 Billion Revenue Run Rate as AUVELITY Sales Surge ↗
Via MarketBeat
Tickers AXSM
Exposures Product Safety
News headline image
Definium (DFTX) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers DFTX
Exposures Financial Product Safety
News headline image
OraSure Technologies Q3 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers OSUR
Exposures Financial Product Safety
News headline image
What Coherus Oncology (CHRS) Said on Its Q3 Earnings Call ↗
Via MarketBeat
Topics Earnings
Tickers CHRS
Exposures Financial Product Safety
News headline image
What Definium Therapeutics (DFTX) Said on Its Q3 Earnings Call ↗
Via MarketBeat
Topics Earnings
Tickers DFTX
Exposures Financial Product Safety
News headline image
SIGA (SIGA) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers SIGA
Exposures Financial Product Safety
News headline image
Home Age Fit Addresses Adult Bed Rails Safety Following October Federal Recalls and Warning
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
News headline image
Abeona Therapeutics (ABEO) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers ABEO
Exposures Financial Product Safety
News headline image
Why ImmunityBio Stock Dropped 15% After Earnings Despite 53% Sales Growth. Is IBRX Now a Buy? ↗
Via The Motley Fool
Exposures Product Safety
News headline image
What Turning Point Brands (TPB) Said on Its Q3 Earnings Call ↗
Via MarketBeat
Topics Earnings
Tickers TPB
Exposures Financial Product Safety
News headline image
NeurAxis (NRXS) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers NRXS
Exposures Financial Product Safety
News headline image
Vance Thompson Vision Sioux Falls Highlights Dr. John Berdahl's 50,000+ Eye Surgeries and Pioneering Glaucoma Research
Via Press Advantage
Exposures Product Safety
News headline image
Beta Bio: 3 Key Takeaways for Long-Term Investors ↗
Via The Motley Fool
Topics Earnings
Tickers BBNX
Exposures Financial Product Safety
News headline image
What Ocular Therapeutix (OCUL) Said on Its Q3 Earnings Call ↗
Via MarketBeat
Topics Earnings
Tickers OCUL
Exposures Financial Product Safety
News headline image
DBV Technologies Prepares Peanut Patch Launch as FDA Filing Decision Nears ↗
Via MarketBeat
Tickers DBVT
Exposures Product Safety
News headline image
New Independent Research Hub Launches for Eloralintide, Lilly’s Investigational Amylin Agonist
Via Press Release Distribution Service
Topics Supply Chain
Tickers ARM LLY
Exposures Product Safety Supply Chain
News headline image
Wave: 3 Key Takeaways for Long-Term Investors ↗
Via The Motley Fool
Topics Earnings
Tickers WVE
Exposures Financial Product Safety
News headline image
What Zimmer Biomet (ZBH) Said on Its Q3 Earnings Call ↗
Via MarketBeat
Topics Earnings
Tickers ZBH
Exposures Financial Product Safety
News headline image
Why Royalty Pharma Investors Could Be the Quiet Winners From Revolution Medicines' Groundbreaking Pancreatic Cancer Drug ↗
Via The Motley Fool
Topics Intellectual Property
Tickers RPRX RVMD
Exposures Intellectual Property Product Safety
News headline image
Mountain Home, AR Author Recounts His Search for the Ivory-Billed Woodpecker
Via PR Leap
Topics Product Recall
Tickers AMZN
Exposures Legal Product Safety
News headline image
Certified PEP MEX Expands Its Reach in Mexico With Two New Research Peptide Websites
Via Press Release Distribution Service
Tickers FDX LLY
Exposures Product Safety
News headline image
Satellos Bioscience Sets Duchenne Trial Endpoint After FDA Talks, Eyes 2027 Results ↗
Via MarketBeat
Tickers MSLE
Exposures Product Safety
News headline image
Braveheart Bio Shares One-Year Heart Drug Data, Plans New Fixed-Dose Trial ↗
Via MarketBeat
Tickers BRVE
Exposures Product Safety
News headline image
What SAB Biotherapeutics (SABS) Said on Its Q3 Earnings Call ↗
Via MarketBeat
Topics Earnings
Tickers SABS
Exposures Financial Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >